Bakkt Holdings
BKKT
Mawson Infrastructure
MIGI
BIT Mining
BTCM
4
Riot Platforms
RIOT
5
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 32.150
- -0.170-0.53%
Close Mar 21 16:00 ET
- 32.150
- 0.0000.00%
Post 16:00 ET
1.79BMarket Cap24.36P/E (TTM)
32.900High31.970Low2.25MVolume31.970Open32.320Pre Close72.40MTurnover4.64%Turnover Ratio24.36P/E (Static)55.81MShares40.28052wk High1.73P/B1.56BFloat Cap25.53052wk Low--Dividend TTM48.49MShs Float61.250Historical High--Div YieldTTM2.88%Amplitude4.300Historical Low32.169Avg Price1Lot Size
Supernus Pharmaceuticals News
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DEC TIMOTHY C
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DEC TIMOTHY C
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DEC TIMOTHY C
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 10-K: FY2024 Annual Report
Supernus Pharmaceuticals | 8-K: Supernus Announces Fourth Quarter and Full Year 2024 Financial Results
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DEC TIMOTHY C
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings